DoW, Ovarian Cancer, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $16.5M
- Closes
- Oct 1, 2026 (in 15 days)
Similar opportunities open now
- DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW Ovarian Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW, Ovarian Cancer, Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW, Peer Reviewed Cancer, Impact AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 19 days
- DoW Vision, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 57 days
Classification and identifiers
- Solicitation number
- HT942526OCRPIIRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $16.5M
Who can apply
About this opportunity
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering projec...